AI-Based Conversational Social Support for Older Adults With Heart Failure
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age60+
SponsorChang Gung University of Science and Technology
About this trial
This three-year study aims to investigate gender differences in social frailty and evaluate the effects of an artificial intelligence (AI)-based conversational social-support intervention among older adults with chronic heart failure (CHF).
The study plans to enroll 300-500 adults aged 60 years or older from four Chang Gung Memorial Hospital branches in Taiwan.
In the first phase, researchers will assess participants' clinical characteristics, sarcopenia, physical activity, and physical, psychological, and social frailty. The study will examine gender differences and identify factors associated with social frailty.
In the second phase, 174 participants are planned to be assigned to three groups: an AI-based conversational social-support group, a community social participation group, and a control group. The AI group will engage in daily 15-30-minute app-based conversations, while the community group will be encouraged to participate in regular social activities. The control group will maintain routine activities.
The third phase will assess longer-term changes in social frailty, emotional well-being, physical activity, and health outcomes, with follow-up assessments at 1, 3, 6, and 12 months after the intervention.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Participants aged 60 years or older.
Diagnosis of chronic heart failure (CHF).
Ability to communicate effectively in Mandarin or Taiwanese.
Disqualifiers
Unstable heart failure.
Severe comorbidities, such as end-stage renal disease, advanced hepatic dysfunction, or terminal malignancies.
Severe cognitive deficits that impede the ability to provide informed consent or participate in study interventions.
Uncorrected visual or hearing impairments that hinder effective communication or interaction with the AI-based conversational social-support intervention.
Trial design
Design model
Parallel
Treatments tested in this trial
AI-Based Conversational Social Support
BehavioralParticipants will receive an AI-based conversational social-support intervention delivered via a tablet. The intervention is designed to provide social interaction and support for older adults with heart failure.
Community Social Participation
BehavioralParticipants will be encouraged to attend regular community social activities to enhance social interaction, with continued care and follow-up by telephone.
Treatment groups
174 Participants
are divided into 3 treatment groupsGroup A: AI Conversational Support GroupExperimental treatment 1 intervention
Group B: Community Social Participation GroupActive comparator 1 intervention
Group C: Control GroupNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
Change in Social Frailty Score
Change in social frailty will be assessed using the five-item Makizako Social Frailty Index. Scores will be compared across the AI conversational support group, community social participation group, and control group.
Time frame
Baseline and 1, 3, 6, and 12 months after interventionSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov